Brian A. Fairchild

Brian Fairchild, a partner in Goodwin Procter’s Technology & Life Sciences Group, counsels companies and their investors on the evaluation and development of patent portfolios. Dr. Fairchild works with these companies to develop U.S. and foreign patent protection, and assess and reposition existing patent portfolios to maintain relevance in a changing competitive landscape. In addition, he has experience conducting intellectual property due diligence investigations in anticipation of acquisitions, investments in privately held companies and public offerings; evaluating the enforceable scope of patent protection held by third parties analyzing patent infringement and validity issues; and providing strategies for risk reduction.

Dr. Fairchild works primarily in the life sciences, with a focus on protein pharmaceuticals and antibody technologies; protein synthesis and formulation; nucleic acid sequencing, detection, synthesis, and therapies; protein-and nucleic acid-based diagnostic technologies; stem cells; and microbial detection.

Good to know

Areas of Practice 1) Patent Prosecution & Counseling, 2) Technology Transactions, 3) Life Sciences and 4) Patent Litigation
Law School Suffolk University Law School (J.D., 2003)
Education Massachusetts Institute of Technology (Ph.D., 1999)
Bar Member / Association Massachusetts
Most recent firm Goodwin Procter LLP
Barbara A. Fitzgerald
Barbara A. Fitzgerald

Ms. Fitzgerald represents employers in a wide range of industries, including the entertainment, financial services, hospitality, manufacturing, retail, and transportation industries.

Barton W S Bassett
Barton W S Bassett

Barton W.S. Bassett is the leader of Morgan Lewis's Tax Practice. Mr. Bassett's practice focuses on international tax planning for both the outbound operations of U.S. multinationals and the inbound operations of foreign multinationals.

Benjamin P. Smith
Benjamin P. Smith

Benjamin P. Smith is a partner in Morgan Lewis's Litigation Practice. He is a trial lawyer with a particular focus on high-stakes disputes in the biotechnology, medical device, and internet industries.